The first European participants in a Phase 2 trial of the Parkinson's gene therapy AB-1005 have been randomly assigned to treatment groups.| Parkinson's News Today
Xingimaging and Synusight received a MFJJ grant to develop PET imaging technology that monitors toxic protein clumps in Parkinson's.| Parkinson's News Today
Parkinson's research and development moves far too slowly, says columnist Doc Irish, who argues for a more innovative and dynamic system.| Parkinson's News Today
Columnist Mary Beth Skylis shares instances where technology can support a better quality of life for Parkinson's disease patients.| Parkinson's News Today
The recipients of this year's grants include scientists and clinicians studying Parkinson’s biology, brain networks, and symptoms.| Parkinson's News Today
Expanding access to specialist healthcare for Parkinson's is increasingly urgent as the number of patients rise in the U.S., researchers say.| Parkinson's News Today
Analyzing real-world patient data may help researchers better understand Parkinson’s causes, its early signs, and responses to therapy.| Parkinson's News Today
In a mouse model of Parkinson’s, continuous exposure to low-oxygen air eased or even reversed motor symptoms and slowed disease progression.| Parkinson's News Today
Insilico said it plans to ask the FDA this year for permission to move an AI-designed Parkinson's therapy into clinical trials.| Parkinson's News Today
The first three Parkinson's patients who received ANPD001 saw improvements in motor symptoms and daily functioning, early trial data showed.| Parkinson's News Today
A recent study confirmed columnist Mollie Lombardi's observations about the different ways women and men approach DBS surgery for Parkinson's.| Parkinson's News Today
In the first of a four-part series on deep brain stimulation for Parkinson's, columnist Mollie Lombardi describes her initial DBS surgery.| Parkinson's News Today
A sweet story has a cringeworthy ending for columnist Christine Scheer, who lost her sense of smell and taste because of Parkinson's.| Parkinson's News Today
Target enrollment is complete for a Phase 1b trial testing the safety and tolerability of GT-02287 in people with Parkinson’s disease.| Parkinson's News Today
Columnist Doc Irish pays tribute to his dog, Jax, in a reflection on aging that also looks at his own life with Parkinson's disease.| Parkinson's News Today
Routine evaluations and adjustments provide columnist Mollie Lombardi the best results with her deep brain stimulator.| Parkinson's News Today
Columnist Mollie Lombardi hopes she doesn't experience the Parkinson's dementia that her grandpa had to endure.| Parkinson's News Today
Side-to-side eye movements reduced body sway in people with Parkinson's disease in a study of 10 people with Parkinson's and 11 without it.| Parkinson's News Today
Most Parkinson's patients experience a range of walking difficulties, resulting in distinctive gait and balance problems.| Parkinson's News Today
Columnist Mollie Lombardi shares how her early-onset Parkinson's disease diagnosis has affected her husband and their marriage.| Parkinson's News Today
When choosing members of your healthcare team, don't settle for just "OK," says columnist Christine Scheer. Advocating for yourself is key.| Parkinson's News Today
Focused ultrasound, a minimally invasive technology, will soon be available at Vanderbilt to treat essential tremor and Parkinson’s disease.| Parkinson's News Today
Columnist Christine Scheer compares her Parkinson's symptoms today with their severity before she had deep brain stimulation surgery.| Parkinson's News Today
Columnist Mary Beth Skylis shares tips for positive coping skills that she encourages her dad, who has Parkinson's, to implement.| Parkinson's News Today
The American Parkinson Disease Association (APDA) has awarded $2.6 million to research projects aiming to better understand Parkinson's.| Parkinson's News Today